Health officials from the Data and Safety Monitoring Board, DSMB, expressed concern that the U.S. trial of the AstraZeneca vaccine may have used out of date information which gave an "incomplete view" of the efficacy. It was previously reported that the vaccine provided 79 percent efficacy against Covid-19.
» Subscribe to NBC News: [ Ссылка ]
» Watch more NBC video: [ Ссылка ]
NBC News Digital is a collection of innovative and powerful news brands that deliver compelling, diverse and engaging news stories. NBC News Digital features NBCNews.com, MSNBC.com, TODAY.com, Nightly News, Meet the Press, Dateline, and the existing apps and digital extensions of these respective properties. We deliver the best in breaking news, live video coverage, original journalism and segments from your favorite NBC News Shows.
Connect with NBC News Online!
NBC News App: [ Ссылка ]
Breaking News Alerts: [ Ссылка ]
Visit NBCNews.Com: [ Ссылка ]
Find NBC News on Facebook: [ Ссылка ]
Follow NBC News on Twitter: [ Ссылка ]
Follow NBC News on Instagram: [ Ссылка ]
#AstraZeneca #Trial #NBCNews
Health Experts Question Efficacy Results Of U.S. AstraZeneca Trial | NBC News NOW
